Elyse Stock
2019
Compensation breakdown
| Bonus | $198,563 |
|---|---|
| Option Awards | $1,098,126 |
| Salary | $378,216 |
| Stock Awards | $774,900 |
| Other | $17,610 |
| Total | $2,467,416 |
Stock received $1.1M in option awards, accounting for 45% of the total pay in 2019.
Stock also received $198.6K in bonus, $378.2K in salary, $774.9K in stock awards and $17.6K in other compensation.
Rankings
In 2019, Elyse Stock's compensation ranked 4,920th out of 13,971 executives tracked by ExecPay. In other words, Stock earned more than 64.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,920 out of 13,971 | 65th |
Division Manufacturing | 1,830 out of 5,701 | 68th |
Major group Chemicals And Allied Products | 640 out of 2,200 | 71st |
Industry group Drugs | 540 out of 1,886 | 71st |
Industry Pharmaceutical Preparations | 404 out of 1,398 | 71st |
Pay ratio
| Elyse Stock's Pay | $2,467,416 |
|---|---|
| Median Employee's Pay | $165,840 |
| Pay Ratio | 15to 1 |
In 2019, the annual total compensation of Elyse Stock was $2,467,416.
The annual total compensation of the median employee at Biohaven Pharmaceutical Holding Co Ltd. was $165,840.
The ratio of Elyse Stock's pay to the pay of median employee was therefore 15 to one.
Stock's colleagues
We found four more compensation records of executives who worked with Elyse Stock at Biohaven Pharmaceutical Holding Co Ltd. in 2019.
2019
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
2019
William Jones
Biohaven Pharmaceutical Holding Co Ltd.
Chief Commercial Officer of Migraine & Common Diseases
2019
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.
Senior Vice President, Clinical Operations
2019
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.